Please check your internet connection and try again.
# Megacv Duo (Amoxicillin/Clavulanate Potassium)
## Overview
Megacv Duo is an oral combination antibiotic consisting of amoxicillin (a beta-lactam penicillin) and clavulanate potassium (a beta-lactamase inhibitor). The addition of clavulanate expands the spectrum of activity to include beta-lactamase-producing organisms.
## Primary Indications
Used for infections caused by susceptible organisms, including:
* Acute bacterial rhinosinusitis.
* Community-acquired pneumonia.
* Acute otitis media.
* Skin and skin structure infections.
* Urinary tract infections.
## Adult Dosing
Dosage is based on the amoxicillin component.
* **Standard dosing:** 500 mg amoxicillin/125 mg clavulanate every 8 or 12 hours.
* **High-dose (for resistant *S. pneumoniae*):** 875 mg amoxicillin/125 mg clavulanate every 12 hours.
* **Extended-release (XR) formulations:** 2000 mg amoxicillin/125 mg clavulanate every 12 hours.
## Pediatric Dosing
Dosage is typically 20–45 mg/kg/day (based on amoxicillin component) divided every 12 hours, depending on the severity of the infection.
* **Acute Otitis Media:** High-dose (80–90 mg/kg/day) divided every 12 hours is often utilized to overcome resistant *S. pneumoniae*.
* **Note:** Do not use the 875 mg tablet in children weighing <40 kg due to the excessive clavulanate load.
## Dose Adjustments
* **Renal Impairment:** Adjustments required for CrCl <30 mL/min. Avoid using extended-release formulations or the 875/125 mg strength in patients with severe renal failure (CrCl <30 mL/min).
* **Hepatic Impairment:** Use with caution; monitor hepatic function periodically.
## Contraindications
* History of serious hypersensitivity reactions (e.g., anaphylaxis) to amoxicillin, other penicillins, or cephalosporins.
* History of cholestatic jaundice or hepatic dysfunction associated with previous use of amoxicillin/clavulanate.
## Adverse Effects
* **Common:** Diarrhea (frequent), nausea, vomiting, abdominal discomfort, and skin rash (including delayed maculopapular rash).
* **Serious:** *Clostridioides difficile*-associated diarrhea (CDAD), hepatotoxicity (cholestatic jaundice), anaphylaxis, and Stevens-Johnson syndrome.
## Key Drug Interactions
* **Methotrexate:** Amoxicillin may decrease renal elimination, increasing methotrexate toxicity.
* **Warfarin:** May increase INR and bleeding risk; monitor closely if used concurrently.
* **Oral Contraceptives:** Potential for reduced efficacy (though evidence is inconsistent, backup contraception is often advised).
* **Probenecid:** Decreases renal excretion of amoxicillin, increasing serum levels.
## Monitoring
* **Renal/Hepatic:** Monitor periodic liver function tests (LFTs) and renal function, especially during prolonged therapy.
* **Allergy:** Assess for signs of hypersensitivity (rash, urticaria, wheezing).
* **Gastrointestinal:** Monitor for persistent diarrhea or signs of *C. difficile* infection.
## Clinical Pearls
* **Administration:** Take with food or a meal to minimize gastrointestinal upset.
* **Clavulanate content:** The ratio of amoxicillin to clavulanate varies by tablet strength. Always verify the specific mg/mg formulation prior to prescribing.
* **Resistance:** Do not use for suspected viral infections.
* **Local Protocols:** Dosing for specific pathogens (e.g., community-acquired pneumonia) must align with institutional antibiograms and local antimicrobial stewardship guidelines.
***
**Educational Disclaimer:** This information is for educational purposes only. Always consult current institutional guidelines, the product’s official prescribing information, and clinical databases (e.g., Lexicomp, UpToDate) before prescribing or administering medication.
